CD38–RyR2 axis–mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer

Proceedings of the National Academy of Sciences, Volume 121, Issue 11, March 2024.
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : National Academy of Sciences – https://www.pnas.org/doi/abs/10.1073/pnas.2315989121?af=R